NantHealth (NASDAQ:NH) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a note issued to investors on Tuesday, January 9th.
NH has been the topic of a number of other research reports. Zacks Investment Research downgraded NantHealth from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th. Jefferies Group reiterated a “buy” rating and issued a $5.00 price objective on shares of NantHealth in a report on Thursday, September 28th. Finally, Canaccord Genuity dropped their price target on NantHealth from $6.00 to $5.00 and set a “buy” rating on the stock in a research note on Friday, November 17th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. NantHealth currently has an average rating of “Buy” and an average price target of $8.05.
NantHealth (NASDAQ:NH) opened at $3.86 on Tuesday. NantHealth has a 12 month low of $2.60 and a 12 month high of $9.86. The company has a current ratio of 2.38, a quick ratio of 2.36 and a debt-to-equity ratio of 0.93. The stock has a market capitalization of $417.07, a PE ratio of -2.17 and a beta of -1.50.
Several institutional investors and hedge funds have recently bought and sold shares of the company. Alliancebernstein L.P. acquired a new position in NantHealth during the second quarter worth $102,000. GSA Capital Partners LLP acquired a new position in NantHealth during the second quarter worth $121,000. Teachers Advisors LLC raised its holdings in NantHealth by 351.8% during the second quarter. Teachers Advisors LLC now owns 31,578 shares of the company’s stock worth $134,000 after purchasing an additional 24,588 shares during the last quarter. California State Teachers Retirement System raised its holdings in NantHealth by 132.4% during the second quarter. California State Teachers Retirement System now owns 31,600 shares of the company’s stock worth $134,000 after purchasing an additional 18,000 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. acquired a new position in NantHealth during the third quarter worth $180,000. 7.10% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: This story was first posted by BBNS and is the property of of BBNS. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://baseballnewssource.com/markets/nanthealth-nh-upgraded-to-sell-by-bidaskclub/1819778.html.
NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.